In partnership with

 Gainers📈 & Losers📉

Our Biggest Gainers & Losers of the Day in the $100,000 Build Portfolio

For the 26th November 2024:

• The Diet Pill Jackpot 💊💰

• 111% Gain in 10 Days 🤯 

The Diet Pill Jackpot 💊💰

It’s a great day to be selling weight loss cheat codes.

The Biden admin just made a move that could super-size the market for anti-obesity drugs. The market loved it & that’s what made Eli Lilly & Co my biggest gainer for today.

So why did the market love it? What’s actually going to happen?

Right now, Medicare & Medicaid only cover anti-obesity meds for specific conditions like diabetes. The new proposal has the potential to put these drugs in the chubby hands of 3.4M more Americans.

If this passes, big pharma get access to 3.4 million more customers overnight. That’s why the market loved it.

 Who’s Getting the Gains?🍟

Now we know why it’s good news, who’s set to make the most money? And more importantly, how can we make the most money out of it?

Here’s my plan. 🗒️ 

• Big Dogs: Novo & Eli Lilly are the reigning champs in this space. They own the GLP-1 drug market (aka the meds behind Ozempic & Mounjaro). These stocks are heavily undervalued right now even if the bill doesn’t come through. And if it does? No brainer to have these guys as part of a portfolio.

• Underdogs: There’s also a few smaller guys that are undervalued & will benefit from this. I wrote a whole bit on Hims & Hers (HIMS) a few weeks ago that you can read here.

• Insurers: The guys providing the insurance also stand to benefit with the higher enrollment numbers that could come about. I’m looking at companies like UnitedHealth (UNH), Humana (HUM), & CVS (CVS).

Show Me the Money🤑

If Biden gifting millions more more customers wasn’t enough, Morgan Stanley have also come out & raised their forecasts for the space.

Their 2030 obesity drug market forecast has bumped from a single patty $77B to a Big Mac $144B.

That’s a huge revision & only makes companies like Eli Lilly & Novo look like even more of a value play.

Why would you not want a part of the companies with a monopoly on a market expected to grow by $144 BILLION in the next 5 years?!

Could this be the biggest disruption to Smartphones in the past 15 years? 📲

💥Heads up! There's a new disruptor in smartphones: Mode Mobile. Mode can turn your phone from a cost into an income source — and investors are watching the launch of the company’s pre-IPO offering.¹

🤳Mode saw 32,481% revenue growth from 2019 to 2022, ranking them the #1 overall software company on Deloitte’s most recent fastest-growing companies list. Mode’s flagship product EarnPhone, a budget smartphone, has already helped consumers earn & save $325M+.

🫴 Mode’s Pre-IPO offering¹ is live at $0.25/share — 20,000+ shareholders already participated in its previous sold-out offering. There’s still time to get in on Mode’s pre-IPO raise and even lock in 100% bonus shares² … but only until their current raise closes for good.

Claim this exclusive bonus while you can!³

¹ Mode Mobile currently has no formal plans for an IPO.
² A minimum investment of $1,950 is required to receive bonus shares. 100% bonus shares are offered on investments of $9,950+.
³ Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering.
Past performance is no guarantee of future results. Start-up investments are speculative and involve a high degree of risk. Those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.
DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 105 Maxess Road, Suite 124, Melville, NY 11747, is the Intermediary for this offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA's BrokerCheck.

111% Gain in 10 Days 🤯 

SMCI’s volatility is putting meme stocks to shame. What is going on with them? Is it worth trying to cash in?

Well, it’s a bit of a messy back story.

Last month, SMCI tanked 47% in four straight days.

Why?

Ernst & Young, their auditor, quit & said, “Yeah, we don’t trust your governance and internal controls.” 😬

Less than ideal. Even worse is this news came out the day after I bought my first position. 😭How’s that for timing the market….

Investors ran for the hills & you can’t blame them. And just when you thought it couldn’t get any worse, SMCI delayed its 10-K filing & dropped some “meh” guidance for Q2.

By November 15, the stock hit a 52-week low. Pain.

The Plot Twist 🌹 

As this was going on I carried on averaging down. Only small positions. But I thought the risk/reward was worth it after such a huge drop. I already thought the company was good value before the price was cut in half. I wasn’t sold on the idea of them cooking the books so if that’s case I’d be stupid to not take advantage.

They didn’t let me down.🥳 

They brought in BDO USA as their new auditor. Not one of the Big Four, but solid enough to calm nerves, make me feel better & keep Nasdaq delisting fears away.

A few analysts have also slapped them with an upgrade since & chucking around phrases like “bargain buying opportunity”.

Since bottoming out at around $16 SMCI gained over 111% in 10 days.

Because I’ve been averaging in, that’s left me with individual trades sitting at over 90% profit. Overall profit sits at over 20%.

To be super clear - a position in SMCI is a big risk. But I think there’s huge upside here, too. I’m talking 200%+.

If they can manage to stay listed, updated audits come back clean & get a few solid quarters under their belt hitting growth forecasts, things should start to look sane again.

Until then, expect to these double figure daily swings to be the norm. If you can stomach it & invest only what you’re happy to lose, this could be one of the better opportunities available right now.

That’s all! See you same time tomorrow 👋 

P.S Hit reply & let me know what you thought of today’s newsletter. All feedback is welcomed ❤️